Regencell Bioscience, a company focusing on Traditional Chinese medicine for neurocognitive disorders, announced on May 26, 2026, that Amundi bought shares during Q1, with stock trading on the NASDAQ electronic stock exchange.
3 reports, 2 independent
Updated Jun 26
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Regencell Bioscience, a company focusing on Traditional Chinese medicine for neurocognitive disorders, announced on May 26, 2026, that Amundi bought shares during Q1, with stock trading on the NASDAQ electronic stock exchange.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Regencell Bioscience
traditional Chinese herbal treatment company
Nothing else this week.
-
TCM
Nothing else this week.
-
Amundi
French subsidiary jointly created by Crédit Agricole and Société Générale